Daiwa Securities Adjusts Price Target on AbbVie to $190 From $180, Keeps Neutral Rating

Trading View
2025.02.04 13:44

根據 FactSet 調查的分析師，艾伯維的平均評級為 “增持”，平均價格目標為 207.40 美元

根據 FactSet 調查的分析師，艾伯維的平均評級為增持，平均目標價格為 207.40 美元。

Source: Trading View The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.